Sarasin & Partners’s Pfizer PFE Stock Holding History

Sarasin & Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.4M	Sell	845,257 -510,530	-38%	-$13.4M	0.24%	41
2026 Q1	$38.1M	Sell	1,355,787 -59,507	-4%	-$1.58M	0.46%	41
2025 Q4	$35.2M	Sell	1,415,294 -4,112	-0.3%	-$104K	0.37%	38
2025 Q3	$33.9M	Sell	1,419,406 -35,092	-2%	-$866K	0.33%	38
2025 Q2	$35.3M	Sell	1,454,498 -18,354	-1%	-$428K	0.35%	39
2025 Q1	$37.3M	Buy	1,472,852 +41,912	+3%	+$1.1M	0.4%	38
2024 Q4	$38M	Buy	1,430,940 +341,539	+31%	+$9.26M	0.42%	31
2024 Q3	$31.5M	Sell	1,089,401 -21,778	-2%	-$635K	0.3%	37
2024 Q2	$31.1M	Sell	1,111,179 -293,956	-21%	-$8.09M	0.28%	39
2024 Q1	$39M	Buy	1,405,135 +22,504	+2%	+$624K	0.38%	38
2023 Q4	$39.8M	Buy	1,382,631 +969,973	+235%	+$29.3M	0.44%	39
2023 Q3	$13.7M	Sell	412,658 -156,199	-27%	-$5.52M	0.17%	50
2023 Q2	$20.9M	Sell	568,857 -351,541	-38%	-$13.7M	0.24%	47
2023 Q1	$44.4M	Buy	920,398 +484,458	+111%	+$20.9M	0.24%	60
2022 Q4	$22.3M	Buy	435,940 +9,012	+2%	+$432K	0.29%	51
2022 Q3	$18.7M	Buy	426,928 +9,231	+2%	+$449K	0.26%	55
2022 Q2	$21.9M	Buy	417,697 +13,635	+3%	+$695K	0.28%	56
2022 Q1	$20.9M	Sell	404,062 -52,639	-12%	-$2.73M	0.21%	61
2021 Q4	$27M	Sell	456,701 -148,828	-25%	-$7.37M	0.25%	61
2021 Q3	$26M	Sell	605,529 -92	-0%	-$4.08K	0.26%	60
2021 Q2	$23.7M	Sell	605,621 -1,549	-0.3%	-$60.2K	0.25%	58
2021 Q1	$22M	Sell	607,170 -399,599	-40%	-$14.2M	0.26%	54
2020 Q4	$37.1M	Sell	1,006,769 -702,245	-41%	-$25.8M	0.49%	43
2020 Q3	$59.5M	Sell	1,709,014 -160,126	-9%	-$5.61M	0.86%	38
2020 Q2	$58M	Sell	1,869,140 -2,421,273	-56%	-$82.3M	0.93%	39
2020 Q1	$133M	Sell	4,290,413 -186,067	-4%	-$6.34M	2.61%	16
2019 Q4	$166M	Sell	4,476,480 -151,391	-3%	-$5.39M	2.54%	16
2019 Q3	$158M	Buy	4,627,871 +190,219	+4%	+$6.92M	2.61%	14
2019 Q2	$182M	Buy	4,437,652 +43,017	+1%	+$1.71M	3.19%	8
2019 Q1	$177M	Buy	4,394,635 +32,753	+0.8%	+$1.31M	3.41%	8
2018 Q4	$181M	Sell	4,361,882 -25,549	-0.6%	-$1.06M	3.93%	4
2018 Q3	$183M	Sell	4,387,431 -477,450	-10%	-$18.4M	3.46%	6
2018 Q2	$167M	Buy	4,864,881 +73,562	+2%	+$2.51M	3.29%	8
2018 Q1	$161M	Sell	4,791,319 -477,810	-9%	-$16.4M	3.16%	9
2017 Q4	$181M	Buy	5,269,129 +58,940	+1%	+$2.01M	3.52%	4
2017 Q3	$176M	Sell	5,210,189 -257,908	-5%	-$8.29M	3.56%	4
2017 Q2	$174M	Buy	5,468,097 +265,673	+5%	+$8.38M	3.41%	4
2017 Q1	$169M	Sell	5,202,424 -4,419	-0.1%	-$139K	3.28%	4
2016 Q4	$160M	Buy	5,206,843 +751,053	+17%	+$22.9M	2.71%	9
2016 Q3	$143M	Buy	4,455,790 +1,113,485	+33%	+$37.2M	2.25%	14
2016 Q2	$112M	Sell	3,342,305 -260,321	-7%	-$8.31M	1.85%	22
2016 Q1	$101M	Buy	3,602,626 +2,080,882	+137%	+$59.4M	1.65%	23
2015 Q4	$46.6M	Sell	1,521,744 -40,089	-3%	-$1.26M	0.77%	41
2015 Q3	$46.5M	Sell	1,561,833 -69,450	-4%	-$2.23M	0.84%	39
2015 Q2	$51.9M	Sell	1,631,283 -97,245	-6%	-$3.17M	0.85%	40
2015 Q1	$57.1M	Sell	1,728,528 -61,724	-3%	-$1.96M	0.87%	41
2014 Q4	$52.9M	Sell	1,790,252 -120,854	-6%	-$3.47M	0.79%	40
2014 Q3	$53.6M	Sell	1,911,106 -66,562	-3%	-$1.87M	0.74%	42
2014 Q2	$55.7M	Sell	1,977,668 -8,207,451	-81%	-$234M	0.78%	39
2014 Q1	$310M	Buy	10,185,119 +218,874	+2%	+$6.53M	4.43%	3
2013 Q4	$290M	Sell	9,966,245 -231,912	-2%	-$6.75M	4.05%	4
2013 Q3	$278M	Sell	10,198,157 -842,733	-8%	-$22.9M	4.24%	1
2013 Q2	$293M	Buy	+11,040,890	New	+$305M	4.18%	2

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Sarasin & Partners's PFE Position: Q2 2026 in Review

Sarasin & Partners reduced its Pfizer (PFE) stake by 38% in Q2 2026, selling an estimated $13.4M and leaving 845,257 shares worth $20.4M. The position accounts for 0.24% of the portfolio, ranked #41.

Sarasin & Partners first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $310M in Q1 2014. 1,257 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Sarasin & Partners held 845,257 shares of Pfizer worth $20.4M as of Q2 2026.
Sarasin & Partners sold 510,530 Pfizer shares in Q2 2026, an estimated $13.4M.
Pfizer made up 0.24% of Sarasin & Partners's portfolio in Q2 2026, its #41 holding.
Sarasin & Partners first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Sarasin & Partners's Pfizer position peaked at $310M in Q1 2014.
1,257 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sarasin & Partners's 13F filing for Q2 2026, filed 7 Jul 2026.